Table 1.

Inclusion and Exclusion Criteria

Inclusion Criteria
1.	Agrees to written as well as audio-visual informed consent.
2.	Ability to understand the risks/benefits of the protocol.
3.	Male between 35-65 years of age.
4.	Diagnosed with Symptomatic hypogonadism.
Exclusion Criteria
1.	Uncooperative Subjects.
2.	Impaired hepatic function indicated by serum GOT/GPT >2.5 times the upper limit of normal.
3.	Patients suffering from coronary artery disease (CAD) and allied complications.
4.	Abnormal liver or kidney function tests (ALT or AST > 2 times the upper limit of normal; elevated creatinine, males > 125 μmol/L
5.	History of malignancy.
6.	History of hypersensitivity to any of the investigational drugs.
7.	Receiving any other testosterone booster therapy/medication/supplement within the last 2 months.
8.	History of coagulopathies (clotting and bleeding).
9.	High alcohol intake (>2 standard drinks per day).
10.	History of psychiatric disorder that may impair the ability of subjects to provide written informed consent.
11.	Any medical condition, where the investigator feels participation in the study could be detrimental to the subjects overall well-being.